Á lódáil...
Synergism between bosutinib (SKI-606) and the Chk1 inhibitor (PF-00477736) in highly imatinib-resistant BCR/ABL(+) leukemia cells
Interactions between the dual BCR/ABL and Src inhibitor bosutinib and the Chk1 inhibitor PF-00477736 were examined in BCR/ABL(+) leukemia cells, particularly imatinib-resistant cells, including those with the T315I mutation. Bosutinib blocked PF-00477736-induced ERK1/2 activation and sharply increas...
Na minha lista:
Foilsithe in: | Leuk Res |
---|---|
Main Authors: | , , , , , , |
Formáid: | Artigo |
Teanga: | Inglês |
Foilsithe: |
2014
|
Ábhair: | |
Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4413916/ https://ncbi.nlm.nih.gov/pubmed/25465126 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.leukres.2014.10.009 |
Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|